I am a director of the Victorian Chamber of Commerce and the Chair of Linden New Art, Inc. I have lectured in takeover law and regularly present on legal issues.

Career highlights

• Goldman Sachs JBWere – advised on the sale of its margin lending business to Adelaide Bank Limited, valued at over A$900million
• Goldman Sachs - advised on the sale of its iconic JBWere stockbroking and private wealth management business to National Australia Bank
• Svenska Cellulosa AB - advised on its cross-border acquisition of Carter Holt Harvey's Tissue division, Australia and New Zealand's leading consumer and industrial tissue and feminine hygiene and adult incontinence products manufacturer and supplier (transaction value A$890 million)
• Asaleo Care Limited, Svenska Cellulosa AB and Pacific Equity Partners – advised on Asaleo Care's $1.06 billion initial public offering and listing on the Australian Securities Exchange
• CGU Insurance Limited – advised on the creation of Australia’s leading marine insurance specialist – Marine Protect: Powered by NTI. NTI is a joint venture owned and underwritten 50/50 by CGU and AAI
• CGU Insurance Limited and Swann Insurance (Aust) Pty Ltd – advised on the sale of several intermediated insurance distribution business channels to Eric Insurance Limited
• Jemena (a joint venture between State Grid of China and Singapore Power) – advised on its $1 billion+ bid for the Iona gas storage facility. Our work included co-ordinating a multi-jurisdictional team on the legal due diligence and negotiating the transaction documents with the seller and its advisers
• Ceridian HCM Holding, Inc – in its cross-border acquisition of Ascender's Asian payroll and human capital management business

• Recommended by Best Lawyers from 2013 to 2020 for Corporate, M&A and Private Equity, and by IFLR1000
• Rated as one of 8 Leading Individuals in M&A in Australia and praised as having “a brilliant understanding of the market and regulators”
  – The Legal 500 Asia Pacific
• Chambers ranked in M&A

Education
BEc, LLB (Hons)

• Head of the Melbourne Private Equity & Capital Markets Practice Group in ME Corporate
• Corporations Committee of the Law Council of Australia, Member
• Advisory Board of Centre for Corporate and Securities Regulation, University of Melbourne, Member
• Financial Services Institute of Australasia, Member
• Australian Institute of Company Directors, Member
• Director, Chunky Move Limited

• MinterEllison wins contract to advise UK Government free trade agreement negotiations with Australia and New Zealand
  

  The UK government has appointed MinterEllison (Australia) and MinterEllisonRuddWatts (New Zealand) in partnership with UK firm, Hogan Lovells, to advise on the negotiations of the UK-Australia and UK-New Zealand free trade agreements.

• MinterEllison advises on pharma deals for DBG Health
  

  MinterEllison facilitated three acquisitions by DBG Health, valued at over $1 billion, including the purchase of Arrotex Pharmaceuticals, Juno Pharmaceuticals, and Axe Health.

• Activate successful investments in Australia
  

  In this third part of our Investor Sentiment Report, we examine the top considerations for investing in Australian projects with confidence.

• Deals, trends and opportunities from Asia
  

  What are the investment trends and prospects for investors from Asia? We explore them in our Asia Report: Year in Review, looking at China, Japan, Korea and emerging market Indonesia in detail.

• Every company director's corporate governance bible
  

  The Corporate Governance Review: Edition 11 has recently been published, with the Australian Chapter co-authored by our MinterEllison partners.

• MinterEllison awarded Mergermarket's Consumer M&A Advisor of the Year
  

  MinterEllison's Mergers and Acquisition (M&A) team has been recognised as the ing Consumer M&A team at the Australian M&A Awards, hosted by Mergermarket in Sydney on 25 October 2023.

   

• MinterEllison advises Arrotex on key health and beauty acquisitions
  

  Arrotex Pharmaceuticals Australia’s ing generic pharmaceutical and private-label over-the-counter supplier, marks a strategic expansion into the health and beauty sector.

• Essential sectors that drive Australia's economy
  

  In this second part of our Investor Sentiment Report, we delve into the essential sectors that drive Australia's economy.

• Investor Sentiment Study 2023
  

  In this 3-part analysis, we reveal insights into the investment perceptions and intentions of the Australian market by international decision makers.

• Private Capital sets its sights on Australia: MinterEllison report
  

  As the Australian economy moves forward from the pandemic, the outlook for private capital investment continues to improve.

• MinterEllison advises Essity on its proposed $788 million acquisition of Asaleo Care
  

  MinterEllison acted for Essity Aktiebolag, in relation to its proposed acquisition of the remaining 63.8% shares in ASX-listed Asaleo Care Limited 

• UK-EU trade relations: Key Brexit milestones hit, but many steps to go
  

  Following three and half rollercoaster years (which followed five more years of rigorous debate), the United Kingdom looks set to formally withdraw from the European Union with a deal on 31 January 2020. This article explores what is likely to happen during the transition period, and what the implications, challenges and opportunities are for Australian exporters, investors and consumers.

• Scaling new heights: Australian private capital investment outlook
  

  In our report, we take an in-depth look into how private capital managers are viewing the Australian market. What is driving their investment appetite? Where are the best opportunities emerging?